Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine Plus Homoharringtonine”

9 trials

Showing 9 of 9 results

Not applicableStudy completedNCT05456048
What this trial is testing

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Who this might be right for
Relapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaGene Abnormality+1 more
Nanfang Hospital, Southern Medical University 231
Testing effectiveness (Phase 2)Looking for participantsNCT06483906
What this trial is testing

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Who this might be right for
Acute Myeloid Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 56
Large-scale testing (Phase 3)UnknownNCT05457361
What this trial is testing

VAH Versus VA for Salvage Therapy of R/R-AML

Who this might be right for
Venetoclax Combined With Azacitidine Plus HomoharringtonineVenetoclax Combined With Azacitidine
Nanfang Hospital, Southern Medical University 162
Large-scale testing (Phase 3)Not Yet RecruitingNCT07469046
What this trial is testing

VAH vs VA in Newly Diagnosed Elderly AML

Who this might be right for
Acute Myeloid Leukemia (AML)Elderly Patients (60-75 Years)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 308
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07505160
What this trial is testing

Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients

Who this might be right for
Acute Myeloid Leukemia (AML)
Second Affiliated Hospital, Zhejiang University, School of Medicine 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07813390
What this trial is testing

Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangdong Second Provincial General Hospital 73
Large-scale testing (Phase 3)Looking for participantsNCT06810791
What this trial is testing

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University 876
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07517510
What this trial is testing

HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).

Who this might be right for
Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)
Guangdong Second Provincial General Hospital 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation